BackEnanta Pharmaceuticals Overview

Enanta Pharmaceuticals Net Tangible Assets

Latest net tangible assets for ENTA: $120M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$116.59M

Peer average / median

Loading

Enanta Pharmaceuticals Net Tangible Assets History

Loading

Enanta Pharmaceuticals vs. peers: Net Tangible Assets Comparison

Loading

Enanta Pharmaceuticals Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Enanta Pharmaceuticals (ENTA) FAQ

Enanta Pharmaceuticals (ENTA) currently reports a net tangible assets of $120M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Enanta Pharmaceuticals's net tangible assets history and peer comparisons.

Enanta Pharmaceuticals's net tangible assets changed from $0 to $120M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enanta Pharmaceuticals reported $120M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enanta Pharmaceuticals, and consider following ENTA for alerts when major investors trade the stock.

Enanta Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENTA with unrelated industries.